Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|June 4, 2026
Analysis of the differential clinical characteristics of tuberculosis and nontuberculous mycobacterial diseases among AIDS patientsShuibao Xu, Junyang Yang, Jingna Xun, et al.Frontiers in Immunology|June 26, 2025
Plasma proteomic profiling of hospitalized patients co-infected with HIV and SARS-CoV-2Xinyu Zhang, Xuan Yan, Jinfeng Sun, et al.JAMA Internal Medicine|August 19, 2020
Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, ChinaFan Wu, Mei Liu, Aojie Wang, et al.Emerging Microbes & Infections|October 26, 2022
FBXO34 promotes latent HIV-1 activation by post-transcriptional modulationXinyi Yang, Xiaying Zhao, Yuqi Zhu, et al.Emerging Microbes & Infections|March 17, 2025
Monocyte distribution width (MDW) as a reliable diagnostic biomarker for sepsis in patients with HIVJinfeng Sun, Yueming Shao, Rui Jiang, et al.Molecules (Basel, Switzerland)|June 12, 2026
Preparation, Oral SNEDDS Formulation, and In Vivo Evaluation of the HIV-1 Latency-Reversing Agent EK-16ALu Jin, Yuqi Zhu, Fan Yang, et al.Signal Transduction and Targeted Therapy|September 8, 2024
Anti-PD-L1 antibody ASC22 in combination with a histone deacetylase inhibitor chidamide as a "shock and kill" strategy for ART-free virological control: a phase II single-arm studyLuling Wu, Zhihang Zheng, Jingna Xun, et al.Infectious Diseases and Therapy|November 20, 2025
Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical TrialYueming Shao, Xinping Yang, Jianhua Yu, et al.AIDS Research and Therapy|October 20, 2020
Mycobacterium tuberculosis co-infection is associated with increased surrogate marker of the HIV reservoirJingna Xun, Tangkai Qi, Lei Zou, et al.Mbio|July 20, 2021
FKBP3 Induces Human Immunodeficiency Virus Type 1 Latency by Recruiting Histone Deacetylase 1/2 to the Viral Long Terminal RepeatXinyi Yang, Xiaying Zhao, Yuqi Zhu, et al.Pageof 5